In vivo effects of tetrahydrocannabinols and their eight monooxygenated metabolites on the hepatic mi-crosomal drug-metabolizing enzyme systems of mice

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

In vivo effects of tetrahydrocannabinols (THCs) and their eight monooxygenated metabolites on the hepatic microsomal drug-metabolizing enzymes in mice were studied. Δ8-THC and its metabolites (7α-hydroxy-, 7β-hydroxy- and 7-oxo-Δ8-THC, and 8β:, 9β-and 8β, 9β-epoxyhexahydrocannabinol) tended to increase the enzyme contents or activities except for 7β-hydroxy-Δ8-THC which affected the microsomal enzymes in a different manner between the single and subchronic treatments. Single administration (5 mg/kg, i.v.) of 7-oxo-Δ8-THC, 8β, 97β-and 8β, 9β-epoxyhexahydrocannabinol led to a significant increase in hepatic microsomal p-nitroanisole O-demethylase and aniline hydroxylase activities accompanying a significant increase in cytochrome P-450 content in hepatic micro-somes. The same results were obtained with subchronic treatment of mice with these metabolites (5 mg/kg/d, i.v. for 7 d), although the effect of 8β,9β-epoxyhexahydrocannabi-nol on cytochrome P-450 was not statistically significant. 7β-Hydroxy-Δ8-THC significantly increased nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome c reductase and aniline hydroxylase activities by single administration, while the metabolite significantly decreased the contents of cytochrome b5 and P-450 and p-nitrophenol uridine diphosphate-glucuronyltransferase activity by the subchronic treatment. In contrast, Δ9-THC and its metabolites (8a-hydroxy-, 8β-hydroxy- and 8-oxo-Δ9-THC) did not significantly affect the microsomal enzymes by both treatments except that the single administration of 8α-hydroxy-Δ9-THC and the subchronic treatment of Δ9-THC significantly decreased NADPH-cytochrome c reductase activity. These results indicated that monooxygenated metabolites of Δ8-and Δ9-THC affect the hepatic microsomal drug-metabolizing enzyme systems of mice differently. © 1987, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Watanabe, K., Arai, M., Narimatsu, S., Yamamoto, I., & Yoshimura, H. (1987). In vivo effects of tetrahydrocannabinols and their eight monooxygenated metabolites on the hepatic mi-crosomal drug-metabolizing enzyme systems of mice. Journal of Pharmacobio-Dynamics, 10(10), 580–586. https://doi.org/10.1248/bpb1978.10.580

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free